The European League Against Rheumatism (EULAR) recently updated the recommendations for cardiovascular disease (CVD) risk management in patients with rheumatoid arthritis (RA).1 In contrast to the 2009 recommendations which advised to multiply by 1.5 the global CVD risk in the presence of certain RA-specific criteria,2 the 2015/2016 update recommends to multiply by 1.5 the global CVD risk for all patients with RA. It also considers the use of carotid ultrasound to screen asymptomatic atherosclerotic plaques. Indeed, the majority of the CVD events occur in the ‘low’ and ‘intermediate’ risk groups and carotid plaque detection to classify patients improves cardiovascular risk prediction.3 The European Society of Cardiology guidelines classify patients with carotid plaque at very high CVD risk.4 Immediate statin use is indicated in those patients if low-density lipoprotein cholesterol is ≥0.7 g/L.4 In a post hoc analysis, we evaluated the impact of the updated 2015/2016 EULAR CVD recommendations …

中文翻译：

---

2015/2016 EULAR 心血管风险建议在日常实践中的应用：来自观察性研究的数据

欧洲抗风湿病联盟 (EULAR) 最近更新了类风湿性关节炎 (RA) 患者心血管疾病 (CVD) 风险管理的建议。 1 与 2009 年的建议相反，该建议建议将全球 CVD 风险乘以 1.5。某些特定于 RA 的标准，2 2015/2016 更新建议将所有 RA 患者的全球 CVD 风险乘以 1.5。它还考虑使用颈动脉超声筛查无症状的动脉粥样硬化斑块。事实上，大多数 CVD 事件发生在“低”和“中”风险组中，通过检测颈动脉斑块对患者进行分类可提高心血管风险预测。3 欧洲心脏病学会指南将颈动脉斑块患者分类为非常高的 CVD 风险。